Page last updated: 2024-08-22

magnesium sulfate and Central Nervous System Disease

magnesium sulfate has been researched along with Central Nervous System Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brookfield, KF; Vinson, A1
Crowther, CA; Doyle, LW; Marret, S; Middleton, P; Rouse, D1
Beucher, G; Dreyfus, M1
Marret, S1
Crowther, CA; Doyle, LW; Marret, S; Middleton, P1
Clark, RF; Manoguerra, A; Nordt, SP; Smith, D; Turchen, S; Williams, SR1
Ekblad, U; Grönlund, J; Kero, P; Rantonen, T; Rikalainen, H; Välimäki, I1

Reviews

3 review(s) available for magnesium sulfate and Central Nervous System Disease

ArticleYear
Magnesium sulfate use for fetal neuroprotection.
    Current opinion in obstetrics & gynecology, 2019, Volume: 31, Issue:2

    Topics: Central Nervous System Diseases; Dose-Response Relationship, Drug; Female; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Maternal-Fetal Exchange; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Retrospective Studies; Risk Assessment

2019
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    The Cochrane database of systematic reviews, 2009, Jan-21, Issue:1

    Topics: Central Nervous System Diseases; Cerebral Palsy; Female; Fetal Death; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic

2009
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    The Cochrane database of systematic reviews, 2007, Jul-18, Issue:3

    Topics: Central Nervous System Diseases; Cerebral Palsy; Female; Fetal Death; Humans; Infant, Newborn; Infant, Newborn, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic

2007

Other Studies

4 other study(ies) available for magnesium sulfate and Central Nervous System Disease

ArticleYear
[Efficiency of magnesium sulfate for the prevention of eclampsia in women with preeclampsia].
    Gynecologie, obstetrique & fertilite, 2010, Volume: 38, Issue:2

    Topics: Calcium Channel Blockers; Central Nervous System Diseases; Eclampsia; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Treatment Outcome

2010
[Magnesium sulphate: an improvement in the field of preterm infant neuroprotection].
    Gynecologie, obstetrique & fertilite, 2010, Volume: 38, Issue:2

    Topics: Central Nervous System Diseases; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Premature Birth

2010
Hypermagnesemia following an acute ingestion of Epsom salt in a patient with normal renal function.
    Journal of toxicology. Clinical toxicology, 1996, Volume: 34, Issue:6

    Topics: Central Nervous System Diseases; Female; Humans; Magnesium Sulfate; Middle Aged; Muscular Diseases; Musculoskeletal System; Poisoning

1996
Influence of maternal magnesium sulphate and ritodrine treatment on the neonate: a study with six-month follow-up.
    Acta paediatrica (Oslo, Norway : 1992), 1999, Volume: 88, Issue:10

    Topics: Adult; Analysis of Variance; Birth Weight; Central Nervous System Diseases; Female; Follow-Up Studies; Hospitalization; Humans; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Magnesium Sulfate; Male; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Prenatal Care; Prenatal Exposure Delayed Effects; Retrospective Studies; Ritodrine; Statistics, Nonparametric; Tocolytic Agents; Ultrasonography

1999